ASENT's goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
ASENT's 19th Annual Meeting |
||
|
Thank you for attending the 19th Annual American Society of Neurotherapeutics (ASENT) Meeting at the Hilton Washington DC/Rockville Hotel and Executive Meeting Center in Rockville, Maryland. The Pipeline Session is unique to ASENT. Twenty-five (25) presentations were heard about the discovery and development of new CNS therapy candidates. Sessions addressed Alzheimer’s disease, big data, neuromodulation, drug repurposing, regulatory processes for dose determination and prescribing, rapidly-acting antidepressants, pharmacogenetics, the placebo eff ect, and a special session on Parkinson’s disease honoring Stan Fahn, MD, Columbia University, an ASENT founder. |
||
 |
|
 |
In Memory of Jeffrey Nye, M.D., Ph.D |
|
 |
It is with a heavy heart that we announce the passing of Jeffrey Nye M.D., Ph.D. Jeff was a tremendously enthusiastic and committed member of the ASENT leadership. He chaired the Development Committee and, even in the last months of his life, continued to reach out to his extensive professional and personal network to successfully spread the word about this organization and to encourage involvement. Jeff was a delightful man—highly intelligent, incisive and decisive, generous, kind and funny. His passing is a loss not only to ASENT, but to the entire community of those working to bring neurological therapies to patients in need. In his honor, the ASENT Leadership Fund to support annual meeting scholarships to basic and clinical neuroscientists will be renamed the Jeff rey Nye M.D., Ph.D. Leadership Fund. Martha Morrell, MD |
|
|
Coming Soon |
|
 |
ASENT is getting a new look.Mid April Unveiling. |
Neurotherapeutics® is the official journal of ASENT published by Springer.